Aguilar RF

Idioma: Español
Referencias bibliográficas: 29
Paginas: 62-69
Archivo PDF: 128.67 Kb.

RESUMEN

El proyecto genoma humano ha permitido conocer el código genético del hombre, y por lo tanto la estructura del patrimonio hereditario del individuo, lo que permitirá en un futuro quizás no muy lejano alcanzar mejores posibilidades terapéuticas para las enfermedades más prevalentes en el mundo.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kresina TF. An introduction to molecular medicine and gene therapy. Wiley-Liss New Cork 2001:23-43.

2. Murray AW. Whiter genomics? Genome Biology 2000;1(1):31-36.

3. Tenant MR, Miyamoto MM. The role of medical libraries in undergraduate education: a case study in genetics. J Med Libr Assoc 2002;90(2):181-193.

4. Burke W. Genomics as a probe for disease biology. New Engl J Med 2003;349(10):969-974.

5. Ciarleglio LJ, Bennett RL, Williamson J, Mandell JB, Marks JH. Genetic counseling throughout the life cycle. J Clin Invest 2003;112:1280-1286.

6. Shi MM. Technologies for Individual genotyping detection of genetic polymorphism in drugs targestand disease genes. Am Pharmacogenomics 2002;2(3):197-205.

7. Guttmacher AE, Collins FS, Drazen JM. Genomic medicine. The John Hopkins University Press and the New England Journal of Medicine. 2004:402.

8. Green ED. The Human Genome Project. And its Impact On The Study of Human Disease. NISC 2003:201-211.

9. International Human Genome Sequencing Consortium. Initial sequencing and analysis of human genome. Nature 2001;409:860-921.

10. International SNP Map Working Group A map of human genome sequence variation containing 1.42 million single nucleotide polymorphism. Nature 2001;409:928-933.

11. International Human Genome Sequencing Consortium. Science Epigenetics 2001;293(5532):1001-1208.

12. Pagon RA. Genetic diagnosis and counseling. In: Dale Dc, Federman DD. Eds. Subsec VIII. New York NY: Scientific American. Inc Sci Am Med 2001;2(9):290-301.

13. Bird T. Risk and Benefits of DNA testing for Neurogenetic Disorders. Seminars in Neurology 1999;19:253-259.

14. Stankiewics P, Lupski JR. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002;18(2):74-82.

15. Yu A, Zhao C, Fan Y et al. Comparison of human genetic and sequence-based physical maps. Nature 2001;409:951-953.

16. Merikangas KR, Risch N. Genomic Priorities and Public Health. Science 2003;302:599-601.

17. Meléndez-Herrada E. Cervantes-García E, Ramos-González MA, Cravioto A. Impacto de la genómica bacteriana en la medicina humana. Rev Fac Med UNAM 2005;48:18-23.

18. Brodrsossy L. Otigonucleotide microarray microbial diagnostic. Curr Opin Microbiol 2004;7:245-254.

19. Almeida-González L, Franco-Paredes C, Pérez LF, Santos-Preciado JI. Enfermedad por meningococo, Neisseria meningitidis: perspectiva epidemiológica, clínica preventiva. Salud Pública Mex 2004;46:428-450.

20. Matsuura T et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000;26:191-194.

21. Kuokkanen S et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997;61:1379-87.

22. Roses AD. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease. Neurogenetics 1997;1:3-11.

23. Schwartz PJ et al. Genotype-Phenotype correlation in the long-QT syndrome: gene-specific triggers for life threatening arrhythmias. Circulation 2001;103:89-95.

24. Poirier J et al. Apolipoprotein E4 allele as a predictor pf cholinergic deficits and treatment outcome in Alzheimer disease. Proc Acad Sci USA 1995;92:12260-4.

25. Weatherall DJ. Genomics and Global Health: Time for Reappraisal. Science 2003;32:597-598.

26. Sellers TA. Review of proteomics with application to genetic epidemiology. Gen Epidem 2003;24:83-98.

27. Preston RJ. Molecular epidemiology potential impacts on the assessment of public health. Rev Mut Res 2003;543:121-124.

28. Collins FS, Green ED, Guttmacher AE. A vision for the future of genomics research. Nature 2003;422:835-847.

29. Guttmacher AE, Collins PS. Welcome to the Genomic Era. N Engl J Med 2003;349:996-998.